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Abstract.  The RCC1  gene, a  regulator for the onset of 
chromosome condensation was found to encode a  pro- 
tein with a  molecular mass of 45 kD, determined 
using the antibody against the synthetic peptides pre- 
pared according to the amino acid sequence of the 
putative RCC1 protein.  The p45  located in the nuclei 
was released from the isolated nuclei, either by DNase 
I digestion or by treatment with 0.3 M  NaCI.  Consis- 
tently, p45 bound to the DNA-cellulose column was 
eluted with 0.3  M  NaCI.  After sequential treatment 
with DNase I and 2  M  NaCI, almost all of the RCC1 
protein were released from the nuclei. Thus, RCC1 
protein locates on the chromatin and is not a  compo- 
nent of the nuclear matrix.  In mitotic cells, 1M5 is dis- 
persed into the cytoplasm. Presumably, RCC1  protein 
plays a  role in regulating the onset of chromosome 
condensation, at the level of transcription or of mRNA 
maturation. 
C 
HROMOSOME condensation occurs  at  the  transition 
from G2 to M phase in the cell cycle, with the aid of 
maturation promoting factor (MPF) ~  (20, 36).  MPF 
is present in a latent form in the Xenopus oocyte (7, 9) and 
is specifically activated at mitosis by the translation of an ac- 
tivating agent (for review see reference 10). It is therefore as- 
sumed that the interphase cells have a regulatory mechanism 
which represses expression of this activator protein.  This 
view was supported by cell fusion experiments which re- 
vealed that mitosis was delayed in G2 phase cells fused with 
S phase cells (30), and by isolation of mutants with defects 
in negative regulatory factor (s) for MPF activation (23, 26). 
In eukaryotic cells, mitosis does not normally occur until 
DNA synthesis is completed, but, in these mutants, mitosis 
is prematurely induced at interphase under restrictive condi- 
tions. 
In one such temperature-sensitive (ts) mutant, tsBN2, from 
the baby hamster kidney (BHK21) cell line (24, 26) prema- 
ture chromosome condensation (PCC) occurs at 39.5°C. PCC 
is a phenomenon that was first identified in cell fusion exper- 
iments (30):  after fusion with mitotic cells, interphase cells 
undergo rapid transformation resembling that of  G2-prophase 
transition, leading to the formation of discrete chromosomes. 
In the tsBN2 cells, this phenomenon can be induced at the 
restrictive temperature without fusing mitotic cells. In addi- 
tion to PCC, all mitotic-specific events (such as phosphoryla- 
tion of histone H3, appearance of mitotic-specific antigens, 
and synthesis of p35 protein) occur in interphase tsBN2 cells 
at the nonpermissive temperature (2, 39, 40). These mitotic- 
specific events depend on the synthesis of a new protein (24). 
Consistently, tsBN2 cells showing PCC possess the ability 
1.  Abbreviations used in this paper:  MPF,  maturation promoting factor; 
PCC, premature chromosome condensation; ts, temperature sensitive. 
to condense the chromatin of interphase cells by cell fusion 
(14). Thus,  chromosome-condensing factor is newly pro- 
duced in tsBN2 cells at the nonpermissive temperature even 
in cases of arrest at interphase. As the tsBN2 mutation is 
recessive in hybrid cells (22), tsBN2 cells are considered to 
have a ts defect in the negative regulator for the onset of chro- 
mosome condensation, which inhibits the condensation until 
the G2 phase. 
We cloned the human RCC1 gene, complementing tsBN2 
mutation from HeLa ceils, by DNA-mediated gene transfer 
(15).  Using the Alu-free DNA fragment of the RCC1 gene, 
cDNA clones were isolated from Okayama-Berg's cDNA li- 
brary (25). While two of these complement the tsBN2 muta- 
tion, the 5' base sequence of these clones differs. Since both 
clones share the open reading frame of 1,263 bp, we consid- 
ered that this open reading frame may encode the product of 
the RCC1  gene, RCC1 protein.  According to the base se- 
quence of the RCC1 cDNA, the putative RCC1 protein is es- 
timated to have a molecular mass of  45 kD and seven homol- 
ogous internal repeats of ~60 amino acids. 
We prepared  antibodies against the peptides of putative 
RCC1 protein, in attempts to identify the presence of human 
RCC1 protein in HeLa cells. Using these antibodies, human 
RCC1 protein was shown to be a new member of the nuclear 
DNA-binding protein family. It has a molecular mass of 45 
kD,  the same as estimated from the base sequence of the 
cloned cDNA. 
Materials and Methods 
Cell Lines and Culture Condition 
tsBN2 cells are ts mutants derived from the BHK21 cell  line (22), and the 
following cell lines are derivatives  of tsBN2 cells:  BN2-RV, a spontaneous 
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HeLa DNA (22); BN2-peD51,  a ts  + transformant transfected  with the hu- 
man RCCI eDNA (pcD51) (25). The BHK21/13 cell line and the HeLa $3 
cell line are derived from baby golden hamster kidney and from human cer- 
vix carcinoma, respectively,  Cell lines were cultured in a humidified at- 
mosphere containing 10% CO2 at 37.5"C, except for the tsBN2 cells which 
were cultured at 33.5°C. 
Preparation of  Antipeptide Antibodies 
According to the sequence of RCCI  eDNA (25), five peptides (peptide  1, 
KSKKVKVSHRSHSTE;  peptide  2,  ENVMERKKPALVSI;  peptide  3, 
KSRGSRGHVRFQDA;  peptide 4,  LGLGEGAEEKSIPT; and peptide 5, 
HTVLLVKDKEQS)  were synthesized by the solid-phase t-Boc procedure, 
using the Applied Biosystems, Inc. (Foster City, CA) model 430A automated 
synthesizer. Cysteine was added to the carboxy-terminal ends of all peptides 
to couple the carrier proteins. 
Synthetic peptides were coupled to the carrier protein, keyhole  limpet 
hemocyanin or BSA  using N-(r-maleimidobutyryloxy)  succinimide,  and 
then were used to immunize rabbits (33). 
Preparation and Fractionation of Nuclei 
To prepare nuclei, cells were pelleted and washed twice in ice cold hypo- 
tonic buffer containing 10 mM Hepes,  pH 8.0, 5  mM KCI,  and 2  mM 
MgCl2, then incubated in the hypotonic buffer containing 0.5%  NP-40 for 
10  rain  on  ice,  and  disrupted  with  a  tight-fitting  pestle  of  a  Potter 
homogenizer until virtually all cells were broken (usually 25 strokes).  The 
extent of cell breakage was monitored microscopically.  Nuclei  were then 
separated  from the cytoplasmic  fraction by sedimentation at 1,000 g for 5 
rain and washed twice with ice cold hypotonic buffer. The isolated nuclei 
were suspended in the ice cold hypotonic buffer and kept on ice. All proce- 
dures of cell fractiouation  were performed with freshly prepared nuclei, at 
a concentration of l0  s nuclei/ml. In the salt extraction experiments,  the 
hypotonic buffer containing the desired salt concentration was used. Appro- 
priate amounts of a solution containing 2 nag of DNase I per milliliter were 
added  to the  nuclei preparation to obtain the desired concentration of 
nuclease.  All experiments were carried out for 10 rain at 0*C.  Nuclease 
treatment was terminated by adding EDTA (final concentration, 5 raM), fol- 
lowed by an additional incubation for 10 rain on ice.  Nuclear supernatant 
and residual nuclei were separated by centrifugation. Each fraction was ana- 
lyzed by immunobiotting (5,  16). 
Immunobiotting 
Cells were lysed in buffer containing 62.5 mM Tris-HCI,  pH 6.8, 10 mM 
2-mercaptoethanol, 3% (wt/vol) SDS, and 20% glycerol.  Cellular proteins 
were electrophoresed in a  12.5%  SDS-polyacrylamide slab gel (19), and 
analyzed by immunobiotting, as described previously  (5), using the anti- 
body against peptides and a Vectastain ABC kit. Protein concentration was 
determined by Bradford's  method (4). 
Indirect lmmunofluorescence Staining 
Cells growing on glass coverslips were fixed in 3 % (wt/vol) paraformalde- 
hyde in PBS, permeabilized with 1% NP-40 in PBS containing glycine, and 
stained  using  the  anti-peptide  1  and  the  rhodamine-conjngated  goat 
anti-rabbit IgG (Tago Inc., Burlingame, CA), as described elsewhere (6). 
DNA was stained with Hoechst dye 33258 (1 pg/ml) (Hoechst Japan, Ltd., 
Saitama, Japan). 
D NA-binding Assay 
Cells labeled with [35S]methionine were lysed  in buffer A (10 mM Tris- 
HCI, pH 8.0, 1 mM MgCle, 0.5% NP-40, 0.45 M NaCI,  1 mM PMSF, and 
5 pg/ml Pepstatin)  (29).  After dilution with buffer B (10 mM potassium 
phosphate, pH 6.2,  1 mM MgCI2 0.5% NP-40, 1 mM DTT, 10% glycerol), 
the lysate was loaded onto the double-stranded calf thymus DNA-cellulose 
column. Bound proteins were eluted with buffer containing 10 mM Tris- 
HCI, pH 8.0, 1 mM DTT, and increasing concentrations of NaCI. The flow- 
through and the eluted fractions were immunoprecipitated  and analyzed by 
electrophoresis on 12.5 % SDS-polyacrylamide gels. The radioactivity was 
detected  by fluorography. 
Results 
Preparation of  Antibodies to Peptides  Encoded by 
RCC1 cDNA 
Using the cloned human RCC1 genomic DNA as a probe, 
two RCC1 cDNAs complementing the tsBN2 mutation were 
cloned (25). These clones have a different 5' untranslated re- 
gion, but share the open reading frame of 1,263 bp encoding 
a protein of 45 kD, which is estimated to be a product of the 
human RCC1 gene. According to the amino acid sequence 
of this putative RCC1 protein,  five peptides were synthe- 
sized, as described in Materials and Methods, and the loca- 
tion of each is shown in Fig.  1. These peptides were con- 
jugated with BSA or keyhole limpet hemocyanin, as a carrier 
protein, and then used as antigens to immunize the rabbits. 
Identification of  the Putative RCC1 Protein in 
Human Cells 
Of the five synthetic peptide-specific antibodies, the anti- 
peptide 1 antibody recognized the protein with a molecular 
mass of  45 kD, detected in the lysate of HeLa cells by immu- 
noblotting (Fig. 2). Other antibodies which recognized the 
synthetic peptides by Ouchterlony analysis did not specif- 
ically recognize any protein by immunoblotting (data not 
shown). The 45-kD mass is the same as that of the putative 
RCC1 protein estimated from the base sequence. This p45 
protein was also found in two other cell lines, ST2-7 and 
BN2-pcD51,  but not in BHK21  and tsBN2  cells (Fig.  2). 
Both ST2-7 and BN2-pcD51  cells~contain  the active human 
RCC1 gene (genomic and its cDNA, respectively) (15, 25). 
The presence of p45, therefore, is consistent with the pres- 
ence of the active human RCC1 gene. 
From these results, we conclude that the IM5 protein de- 
tected by the antibody to peptide 1 was the product of the hu- 
man RCC1 gene. 
RCC1 Protein Is Located in the Nuclei 
HeLa cells were swollen in hypotonic solution and the intact 
nuclei were collected by gentle centrifugation. Proteins were 
extracted from both cytoplasmic and nuclear fractions, and 
analyzed by immunoblotting using anti-peptide 1. As shown 
in Fig. 3 A, p45  was present only in the nuclear fraction. 
The nuclear location of the p45 was further confirmed by 
indirect immunofluorescence staining. HeLa cells and two 
other cell lines, tsBN2 and ST2-7, grown on glass coverslips 
were fixed, permeabilized, and exposed to anti-peptide  1. 
The  presence  of antibody was  visualized by  rhodamine- 
conjugated goat anti-rabbit IgG. The antibody to peptide 1 
recognizes only the human RCC1 protein. Therefore, stain- 
ing of the cells should be consistent with the presence of ac- 
tive human RCC1 protein. As shown in Fig. 4, the nuclei of 
both HeLa and ST2-7 were stained but the nuclei of tsBN2 
cells were only stained faintly and were barely distinguish- 
able from the cytoplasm. Since both HeLa and ST2-7 cells 
contain the active human RCC1 gene, these results are con- 
sistent with the presence of human RCC1 protein. 
Subnuclear Localization of  RCCI Protein 
To determine whether the RCC1 protein locates on the chro- 
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Figure L  Location of synthetic  peptides  on the open reading frame for putative  RCCI protein.  Complete amino acid sequence of human 
RCCI protein predicted  from its cDNA is indicated  (see reference  25). Regions of the protein selected  for synthesis  are underlined and 
numbered: (1) peptide  1 (amino acid residues  19-33); (2) peptide  2 (residues  52-65); (3) peptide 3 (residues  232-245); (4) peptide  4 
(residues  326-339); and (5) peptide  5 (residues  410-421). 
matin or on the nuclear matrix,  isolated nuclei were treated 
either with nuclease or salt. 
The role of DNA in the nuclear association of  p45 was first 
investigated.  Nuclei  prepared  from  HeLa  cells  were  in- 
cubated in the presence of increasing amounts of DNase I. 
The release of p45 from the nuclei was monitored by immu- 
noblotting with the anti-peptide 1 antibody. Fig. 5 shows that 
whereas p45 was completely retained by the nuclei after in- 
cubation in  the absence of  nuclease,  even a mild nuclease 
digestion  of  DNA  released  ~80-90%  of  the  total  p45.  This 
release  of  p45 correlates  with the extraction  of  DNA  from 
the  nuclei  (data  not  shown). RNA  was not  required  to  retain 
RCCI protein  in  the  nuclei,  since  p45 was not  rclcased  from 
the nuclei  after  digestion  with RNasc A  (200/zg/ml) (data 
not shown). 
Figure 2. Identification  of RCC1 protein by immunoblotting.  Total 
cellular proteins were extracted from the following cell lines: tsBN2, 
BHK21, HeLa $3, BN2-RV, ST2-7, and BN2-pcD51,  as indicated. 
60/zg of each extract was analyzed by immunoblotting,  using anti- 
peptide 1 as the antibody.  The position of p45 is indicated  by the 
arrowhead and the position of molecular mass markers are shown 
at the left in kilodaltons. 
Figure 3. Localization of RCC1 protein in the nuclei.  HeLa $3 cells 
(5  x  106 cells)  were swollen in the presence of 0.5%  NP-40, and 
the nuclei were separated  from the cytoplasm by centrifugation.  60 
#g of protein extracted  from nuclei and cytoplasmic fractions were 
then electrophoresed and analyzed by immunoblotting using anti- 
peptide  l  as the antibody (A) or stained  with Coomassie brilliant 
blue dye (B). As a control, 60 #g of total cellular protein was co- 
electrophoresed. In the ease of Coomassie brilliant  blue staining, 
25 #g of each sample was used. Positions  of the molecular mass 
markers are indicated  on the left in kilodaltons. 
Ohtsubo  ¢ta|. RCCI Protein  1391 Figure 4. Indirect immunofluorescence 
staining of cells. The cell lines tsBN2 
(BN2),  ST2-7  (ST2-7),  or  HeLa  $3 
(HeLa) were  grown  on  glass  cover- 
slips,  fixed,  and  stained  using  anti- 
peptide  1  and  rhodamine-conjugated 
goat anti-rabbit IgG. Bar, 40 t,m. 
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lated nuclei of  HeLa $3 cells by DNase I diges- 
tion. Nuclei (2  x  106) isolated from HeLa $3 
cells were digested with DNase I at concentra- 
tions ranging from 0 to 100 #g/ml for 10 min 
at 0°C and then centrifuged. The proteins re- 
leased into the supernatant (Sup) or present in 
the nuclei (N) were analyzed by immunoblot- 
ting, as described in Materials and Methods. 
The concentration of DNase I used is shown 
above the lanes. The leftmost lane is a bio- 
tinylated SDS-PAGE standard for the molecu- 
lar mass markers (Bio-Rad Laboratories, Rich- 
mond, CA). The molecular masses are shown 
on the left in kilodaltons. The position of p45 
is shown by the arrowhead. 
Approximately  10-20%  of the  total  p45  remained  as- 
sociated with the nuclei after digestion with  100 #g/ml of 
DNase.  At  physiological  salt  concentrations,  the  DNA 
released from nuclease-treated nuclei is present in nucleo- 
protein complexes exhibiting characteristic features of chro- 
matin structure, such as nucleosomal organization or histone 
HI-dependent higher levels of chromatin organization (38). 
The p45 proteins present in the nuclei after digestion with 
100 #g/ml of DNase I may be attached to such a fragmented 
chromatin trapped in the nuclei or to the nuclear matrix (3). 
If  the RCC1 protein which is present in the nuclei after DNase 
I digestion is indeed a component of the nuclear matrix, then 
the p45 would not be released, even in the presence of 2 M 
NaC1 (3). 
Isolated nuclei were incubated in the presence of increas- 
ing concentrations of NaC1.  The release  of p45  from the 
nuclei was monitored by immunoblotting with anti-peptide 
1. As shown in Fig. 6, whereas no p45 was released from in- 
tact nuclei during incubation in buffer to which no salt had 
been added, a concentration of 300 mM NaC1 was effective 
in extracting 80-90% of the total p45.  But even in the pres- 
ence of 400 mM NaCl, some p45 remained in the nuclei. To 
investigate  whether these residual nuclear RCC1 proteins are 
located on the nuclear matrix, the nuclei were digested with 
DNase I (100 #g/ml) and then incubated in the presence of 
2 M NaC1 (Fig.  7). After treatment with 2 M NaCI, p45 was 
not detectable in the nuclei (Fig. 7 A, NM), in which fraction 
only nuclear matrix  proteins  remained  (Fig.  7  B).  Thus, 
RCC1 protein is located on the chromatin and not on the nu- 
clear matrix. 
Figure 6. Salt extraction of RCC1 protein from 
the isolated nuclei of HeLa $3 cells. Nuclei 
(2 x  106) isolated from HeLa cells were in- 
cubated in the presence of NaCl at concentra- 
tions ranging from 0 to 400 mM for 10 min at 
0°C, and then centrifuged.  Proteins released 
into the  supernatant (Sup)  or present  in  the 
nuclei (N) were analyzed by immunoblouing. 
The molar concentrations (M) of NaCl used 
are shown above the lanes and the position of 
p45 is shown by the arrowhead. 
Ohtsubo et ai. RCCI Protein  1393 Figure 7. Sequential extraction of RCCI protein from the 
isolated nuclei of HeLa $3 cells. Nuclei (2  x  106) from 
HeLa cells were incubated in hypotonic buffer containing 
100/~g of DNAase I/ml for 10 min at 0*C, and then cen- 
trifuged. The residual nuclei were further incubated in the 
presence of 2 M NaCI and then centrifuged. (N) Proteins 
extracted from the nontreated nuclei; (DNAase I) proteins 
released into the supernatant after DNase I treatment; (2 M 
NaC1) proteins released after 2 M NaCI treatment; and 
(NM) proteins retained in the final nuclear fraction (nu- 
clear matrix), were eleetrophoresed and analyzed by im- 
munoblotting (A) or stained with Coomassie brilliant blue 
(B). All incubations were carded out for 10 min at 0*C. 
The position of p45 is shown by the arrowhead. The posi- 
tions of the molecular mass markers are indicated on the 
left in kilodaltons. 
RCC1 Proteins in the Mitotic Cell 
Cells growing in culture dishes were fixed without hypotonic 
treatment, so that chromosomes of mitotic cells were con- 
densed, as shown in Fig. 8 B (arrow points to mitotic cells). 
In all mitotic cells examined microscopically, RCC1 proteins 
were dispersed in the cytoplasm as shown in Fig. 8 A, rather 
than associated with chromosomes. 
Binding of  RCC1 Protein to DNA 
The finding that RCC1 proteins were released from the nuclei, 
either by DNase I digestion or by low salt treatment, suggests 
that RCC1 protein binds to chromatin, as a result of its DNA- 
binding activity. To investigate the DNA-binding activity of 
RCC1  protein,  the  total  cellular extract was  subjected  to 
chromatography on a  DNA-cellulose column (Fig. 9). 
Exponentially  growing  HeLa  cells  were  labeled  with 
[35S]methionine,  and the total cellular proteins extracted as 
described  in  Materials  and  Methods.  They  were  then 
charged  onto  a  column  of  double-stranded  calf  thymus 
DNA-cellulose. The bound proteins were eluted with buffer 
containing increasing concentrations of NaCI. Flow-through 
and  eluted  fractions  were  immunoprecipitated,  using  the 
anti-peptide 1 antibody and analyzed by SDS-PAGE. There 
were no p45 proteins in the flow-through and washed frac- 
tions, hence all the p45 proteins were bound to the DNA-cel- 
lulose  column.  At  the  concentration  of 300  mM  NaC1, 
80-90% of  total p45 proteins were eluted from the DNA-cel- 
lulose column. 
At the same concentration, two other proteins (>100 kD 
and 35 kD) were eluted. Since these proteins were immuno- 
precipitated by anti-peptide 1, these high and low molecular 
mass proteins may be present with p45 in a complex form. 
Discussion 
To identify the location of the RCC1 gene product in human 
cells,  we prepared antibodies against peptides synthesized 
according to the putative human RCC1 protein. One of these 
antibodies specifically recognized I>45 protein in the extract 
of HeLa cells. Since the presence of p45 is consistent with 
the presence of  the active human RCC1 gene and the molecu- 
lar mass is the same as that estimated from the amino acid 
sequence of putative RCC1  protein, we concluded that the 
p45 is the human RCC1  protein. 
Only  the  anti-peptide  1  antibody out  of five synthetic 
peptide-specific antibodies  recognized the  RCC1  protein. 
The RCC1  protein has  a  domain  with  seven homologous 
repeats of "°60 amino acids. Peptide 1 is located outside of 
this domain, while others are located inside the repeated do- 
main. Therefore, the inability of peptide-specific antibodies 
to recognize RCC1 protein may reflect a particular structure 
of this protein, as deduced from the base sequence of human 
RCC1  eDNA (25). 
We obtained evidence for the presence of RCC1  proteins 
in the nuclei. The nuclei of both HeLa and ST2-7 cells, but 
not tsBN2 cells were stained with anti-peptide 1. These ob- 
servations are consistent with the presence of human RCC1 
protein. Therefore, the possibility that the nuclei were stained 
artifactually by the anti-peptide 1 antibody can be ruled out. 
DNA plays an important role in locating RCC1 proteins in 
the nuclei, since almost all the RCC1 proteins were released 
by the mild digestion of DNA with DNase I. Also, almost 
all the RCC1  proteins were released from the nuclei by a 
digestion with 300 mM of NaCI. At the same concentration 
of NaCI, RCC1  proteins bound to DNA-cellulose columns 
were effectively  eluted. Thus, the RCC1 protein is associated 
with DNA in a salt labile fashion. Some RCC1 protein was 
released from nuclei after treatment of 0.1  M  NaC1,  and a 
considerable amount was released with 0.2 M  NaCI.  Pre- 
sumably, some of the RCC1 protein was free from chromatin 
in the nucleoplasm. After sequential treatment with DNase 
I and 2 M  NaCI, no RCC1  protein remained in the nuclei. 
Therefore, the RCCI protein is not a component of the nu- 
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tein in mitotic cells. HeLa cells expo- 
nentially  growing on  the  coverslip 
were fixed  and stained  sequentially 
by  anti-peptide  1  and  rhodamine- 
conjugated goat anti-rabbit IgG (A), 
and then with Hoechst 33258 dye (1 
#g/ml) (B). Arrows indicate  the mi- 
totic  cell  with  condensed  chromo- 
somes. Cells in A and B are the same. 
Bar,  25 #m. 
clear matrix. This is further supported by the finding that in 
mitotic cells, RCC1 proteins were dispersed in the cytoplasm. 
Hence, RCC1 protein did not specifically bind to the mitotic 
chromosomes. 
In addition to the 1>45, two other proteins were eluted from 
the DNA-cellulose column using the same concentrations of 
NaCI.  Since  these  proteins  were  immunoprecipitated  by 
anti-peptide  1, which is specific for human RCC1  protein, 
it may be that these two other proteins form a complex with 
RCC1 protein in vivo. These proteins are either essential for 
RCC1 protein binding to DNA or bind DNA with the aid of 
RCC1  protein. 
We cloned both BHK and tsBN2 RCC1 eDNA, using the 
human RCCI eDNA as a probe, and confirmed that the wild- 
Figure  9.  DNA-binding  activity  of 
RCCI protein. About 2  x  107 cells of 
the HeLa cell line labeled with [35S]me- 
thionine were lysed and charged onto a 
double-stranded,  calf thymus, DNA- 
cellulose column. Bound proteins were 
eluted successively with buffer contain- 
ing 0.05, 0.1, 0.3, 0.5, and 1.0 M NaCI. 
After treatment  with  preimmune  se- 
rum,  the  flow-through  (#),  washing 
(w), and the eluted fractions were im- 
munoprecipitated,  using the anti-pep- 
tide  1  antibody  and  formalin-fixed 
Staphylococcus aureus cells.  Precipi- 
tates  were  then  electrophoresed  on 
12.5%  SDS-polyacrylamide gel.  I+C- 
labeled  marker  proteins  (Amersham 
International  Corp.) (M) were coelec- 
trophoresed. The radioactivity was de- 
tected by fluorography. Molecular mass 
standards  are  shown on  left  in  kilo- 
daltons. 
Ohtsubo et al. RCCI Protein  1395 type hamster RCC1 cDNA but not tsBN2 RCC1 eDNA com- 
plemented the tsBN2 mutation.  By comparing the base se- 
quence of both these cDNA,  we found that the RCC1 gene 
has a point mutation in tsBN2  cells (Uchida,  S., T.  Seki- 
guchi, M. Ohtsubo, H. Nishitani, and T. Nishimoto, manu- 
script in preparation).  Based on these results, we concluded 
that the RCC1 gene was indeed the ts mutated gene (tsBN2 
gene) in tsBN2 cells. The phenotype of tsBN2 cells shows 
that it has a ts defect in the negative regulator  for onset of 
chromosome condensation. Thus, the RCC1 gene is proba- 
bly one of the negative regulators  which inhibit the conden- 
sation of chromosomes until  the G2 phase (25,  26). 
Induction of PCC in tsBN2 cells is completely inhibited 
by cycloheximide and partially so by actinomycin D. There- 
fore, we considered that the induction of PCC is regulated 
mainly  in a posttranscriptional  fashion (24).  However, the 
present results  suggest that RCC1 protein functions in the 
nuclei.  Thus,  in somatic cells, there is the possibility that 
RCC1 protein regulates the onset of chromosome condensa- 
tion at the transcriptional  or RNA-processing level, rather 
than translational  level. 
It has recently been shown that purified MPF from Xeno- 
pus and H1 histone kinase from starfish both contain a pro- 
tein closely  related  to p34  cd~2 encoded by the fission yeast 
cell cycle control gene, cdc2 (1,  11,  12,  17). The cdc2 gene 
encodes a protein kinase potentially regulated by phosphory- 
lation  (8,  18,  34).  Consistently,  in fission yeast,  upstream 
regulators  of cdc2  encode putative  protein kinases  (weel ÷ 
and niml+), thereby suggesting that activation  of MPF de- 
pends  on protein  phosphorylation  cascades  (31,  32).  The 
cdc2 gene is also regulated  by another mitotic control gene, 
cdcl3, that encodes a protein with a sequence closely related 
to that of the invertebrate  cyclins (13, 35).  Though the role 
of cyclins in MPF activation  is unknown, translation of cyclin 
mRNA is essential for MPF activation  in the frog Xenopus 
(21,  37). 
The RCC1 protein has no sequence homology with protein 
kinases or cyclins. Since induction of PCC in tsBN2 cells re- 
quires a new protein synthesis and RCC1 protein locates on 
the chromatin, this protein may act as an upstream regulator 
of MPF by playing  a role in repressing the synthesis of cy- 
clins or other activator proteins of MPF, at the level of tran- 
scription, mRNA maturation,  or both. In Aspergillus, a posi- 
tive regulator  of mitosis,  nimA,  shows the mitosis-specific 
expression of mRNA  levels (27).  Like tsBN2  cells,  nimA 
overexpression causes mitotic events even if cells are blocked 
at the S phase (28).  Thus,  RCC1 protein may regulate the 
mRNA levels of the nimA-like gene in mammalians. In any 
case,  RCC1 protein is a first nuclear DNA-binding  protein 
which is involved in MPF activation and the regulation of on- 
set of chromosome condensation.  Functional characteriza- 
tions of this protein are expected to elucidate the early mech- 
anisms involved in the activation  of MPE 
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